HeartSciences reported net income of -$2.75M for the quarter ended Apr 2026. This income statement covers 20 quarters of results from Jul 2021 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jul2021 | Oct2021 | Jan2022 | Apr2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Dec2025 | Apr2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||
| Revenue | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M | 0.00M | ||||||||||
| Cost of RevenueCost of Rev | 0.01M | 854.00 | 0.00M | 0.00M | 760.00 | 0.00M | 0.00M | 0.00M | 760.00 | 0.00M | ||||||||||
| Gross Profit | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M | 0.00M | ||||||||||
| Operating items | ||||||||||||||||||||
| Research & DevelopmentR&D | 0.40M | 0.55M | 0.70M | 1.36M | 0.43M | 0.85M | 0.64M | 0.53M | 0.57M | 0.76M | 0.51M | 1.05M | 1.22M | 1.20M | 1.03M | 0.93M | 1.00M | 0.73M | 0.48M | |
| Selling, General & AdministrativeSG&A | 0.28M | 0.41M | 0.40M | 0.63M | 1.00M | 0.93M | 0.67M | 1.06M | 0.77M | 0.82M | 1.03M | 0.83M | 0.85M | 0.79M | 1.34M | 0.99M | 0.88M | 1.35M | 2.06M | |
| Operating ExpensesOpex | 0.68M | 0.96M | 1.10M | 1.98M | 1.43M | 1.77M | 1.31M | 1.60M | 1.33M | 1.57M | 1.54M | 1.88M | 2.08M | 1.99M | 2.37M | 1.92M | 1.88M | 2.07M | 2.54M | |
| Operating IncomeOp. Inc | -0.67M | -0.96M | -1.10M | -1.98M | -1.43M | -1.77M | -1.31M | -1.60M | -1.33M | -1.57M | -1.53M | -1.88M | -2.08M | -1.99M | -2.37M | -1.92M | -1.87M | -2.07M | -2.54M | |
| EBIT | -0.67M | -0.96M | -1.10M | -1.98M | -1.43M | -1.77M | -1.31M | -1.60M | -1.33M | -1.57M | -1.53M | -1.88M | -2.08M | -1.99M | -2.37M | -1.92M | -1.87M | -2.07M | -2.54M | |
| Non-operating items | ||||||||||||||||||||
| Non Operating Interest Expenses | 0.08M | 0.08M | 0.14M | 0.08M | 0.14M | 0.03M | 0.03M | 0.03M | 0.04M | 0.18M | 0.12M | 0.02M | 0.02M | 0.12M | 0.18M | 0.18M | 0.18M | 0.28M | 0.23M | |
| Other Non Operating IncomeOther Non Op Inc. | 0.25M | 851.00 | 401.00 | 0.00M | 255.00 | 60.00 | 3.00 | 16.00 | 0.05M | 0.05M | 0.02M | 0.01M | 0.01M | 0.00M | 0.00M | 0.01M | ||||
| Non Operating IncomeNon Op. Inc. | 0.17M | -0.08M | -0.14M | -0.08M | -0.14M | -0.03M | -0.03M | -0.03M | -0.04M | -0.18M | -0.12M | 0.03M | 0.02M | -0.10M | -0.16M | -0.17M | -0.18M | -0.28M | -0.21M | |
| Net income details | ||||||||||||||||||||
| EBT | -0.75M | -1.03M | -1.24M | -2.05M | -1.57M | -1.81M | -1.34M | -1.63M | -1.37M | -1.75M | -1.64M | -1.90M | -2.10M | -2.10M | -2.55M | -2.10M | -2.06M | -2.35M | -2.76M | |
| Profit After TaxPAT | -0.50M | -1.03M | -1.24M | -2.05M | -1.57M | -1.81M | -1.34M | -1.63M | -1.37M | -1.75M | -1.64M | -1.85M | -2.05M | -2.08M | -2.54M | -2.09M | -2.05M | -2.35M | -2.75M | |
| Income from Continuing OperationsIncome (Continuing) | -0.75M | -1.03M | -1.24M | -2.05M | -1.57M | -1.81M | -1.34M | -1.63M | -1.37M | -1.75M | -1.64M | -1.90M | -2.10M | -2.10M | -2.55M | -2.10M | -2.06M | -2.35M | -2.76M | |
| Consolidated Net IncomeConsol Net Inc. | -0.75M | -1.03M | -1.24M | -2.05M | -1.57M | -1.81M | -1.34M | -1.63M | -1.37M | -1.75M | -1.64M | -1.90M | -2.10M | -2.10M | -2.55M | -2.10M | -2.06M | -2.35M | -2.76M | |
| Income towards Parent CompanyParent Net Inc | -0.75M | -1.03M | -1.24M | -2.05M | -1.57M | -1.81M | -1.34M | -1.63M | -1.37M | -1.75M | -1.64M | -1.90M | -2.10M | -2.10M | -2.55M | -2.10M | -2.06M | -2.35M | -2.76M | |
| Net Income towards Common StockholdersNet Income | -0.75M | -1.03M | -1.24M | -2.05M | -1.57M | -1.81M | -1.34M | -1.63M | -1.37M | -1.75M | -1.64M | -1.90M | -2.10M | -2.10M | -2.55M | -2.10M | -2.06M | -2.35M | -2.76M | |
| Additional items | ||||||||||||||||||||
| EPS (Basic) | -0.23 | -0.31 | -0.37 | -0.62 | -0.28 | -0.22 | -0.16 | -0.21 | -0.13 | -0.16 | -3.01 | -5.39 | -2.70 | -2.29 | -2.59 | -2.24 | -1.58 | -0.85 | -1.05 | |
| EPS (Diluted) | -0.23 | -0.31 | -0.37 | -0.62 | -0.28 | -0.22 | -0.16 | -0.21 | -0.13 | -0.16 | -3.01 | -5.39 | -2.70 | -2.29 | -2.59 | -2.24 | -1.58 | -0.85 | -0.99 | |
| Shares Outstanding | 3.31M | 3.31M | 3.32M | 3.32M | 5.65M | 8.21M | 8.24M | 7.95M | 10.33M | 10.94M | 0.55M | 0.35M | 0.78M | 0.92M | 0.99M | 0.94M | 1.30M | 2.78M | 2.78M | 2.63M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 3.31M | 3.31M | 3.32M | 3.32M | 5.65M | 8.21M | 8.24M | 7.95M | 10.33M | 10.94M | 0.55M | 0.35M | 0.78M | 0.92M | 0.99M | 0.94M | 1.30M | 2.78M | 2.78M | 2.78M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 3.31M | 3.31M | 3.32M | 3.32M | 5.65M | 8.21M | 9.74M | 7.95M | 10.92M | 11.21M | 0.64M | 0.35M | 0.91M | 0.98M | 1.08M | 1.12M | 1.30M | 3.07M | 2.63M | |
| EBITDA | -0.67M | -0.96M | -1.10M | -1.98M | -1.43M | -1.77M | -1.31M | -1.60M | -1.33M | -1.57M | -1.53M | -1.88M | -2.08M | -1.99M | -2.37M | -1.92M | -1.87M | -2.07M | -2.54M | |
| Interest ExpensesInt Expense | 0.08M | 0.08M | 0.14M | 0.08M | 0.14M | 0.03M | 0.03M | 0.03M | 0.04M | 0.18M | 0.12M | 0.02M | 0.02M | 0.12M | 0.18M | 0.18M | 0.18M | 0.28M | 0.23M |